Epidemiological study of the association between anti-Lutzomyia longipalpis saliva antibodies and development of delayed-type hypersensitivity to Leishmania antigen.
about
Determinants for the development of visceral leishmaniasis diseaseProfiling of human acquired immunity against the salivary proteins of Phlebotomus papatasi reveals clusters of differential immunoreactivity.Seroconversion to Lutzomyia intermedia LinB-13 as a biomarker for developing cutaneous leishmaniasis.Salivary gland transcriptomes and proteomes of Phlebotomus tobbi and Phlebotomus sergenti, vectors of leishmaniasis.Immunodominant antigens of Leishmania chagasi associated with protection against human visceral leishmaniasis.Comparative analysis of salivary gland transcriptomes of Phlebotomus orientalis sand flies from endemic and non-endemic foci of visceral leishmaniasis.New Insights on the Inflammatory Role of Lutzomyia longipalpis Saliva in LeishmaniasisThe immune response to sand fly salivary proteins and its influence on leishmania immunityInterleukin 10-Dominant Immune Response and Increased Risk of Cutaneous Leishmaniasis After Natural Exposure to Lutzomyia intermedia Sand Flies.Biomarkers for exposure to sand flies bites as tools to aid control of leishmaniasis.Immunity to Lutzomyia whitmani Saliva Protects against Experimental Leishmania braziliensis InfectionSand-fly saliva-leishmania-man: the trigger trioInsights into the sand fly saliva: Blood-feeding and immune interactions between sand flies, hosts, and LeishmaniaHuman cellular and humoral immune responses to Phlebotomus papatasi salivary gland antigens in endemic areas differing in prevalence of Leishmania major infection.Antibody response to sand fly saliva is a marker of transmission intensity but not disease progression in dogs naturally infected with Leishmania infantum.Biomarkers for Zoonotic Visceral Leishmaniasis in Latin America
P2860
Q27027871-70E4B824-69CD-4C8B-9669-F30E972A30CFQ33588558-6B88D5D3-65F4-444E-9AA8-CE2B5C1593CAQ33784499-7358B0B1-4919-48C1-B439-D9A119385E75Q34282246-3DFB332E-E607-48D0-8DBF-D2D04E785E39Q34314499-E4FF79A1-6B1D-4F81-B48F-8A5E1D6A5FF4Q35109201-71E30449-8DDE-4CAF-BD1B-D3E961E1B4A7Q35838090-7DC17919-3EF3-45A9-BF76-B347D29672A6Q35952185-007C3A47-2336-4AE3-83CB-09C4363862A9Q35965262-EF447284-3E90-47D4-9D10-207560867D81Q35974756-644A8B0F-0E50-422D-9747-2638196EDEA2Q36182015-F44A2DAD-B640-4329-AEF6-800E924C26EAQ37321931-F52DEABC-815D-41BB-9610-69D9D4A62A38Q38680919-49412EA0-CFE5-4BC9-A233-8D90FC3236A9Q45412433-9EE3F5DB-7A24-4B82-897A-B2B2229F7B93Q48307725-A438D1FE-780D-4B94-8602-17E3B2E08722Q57952511-5868FDC8-6B2C-4EF5-9CAE-D64B51704341
P2860
Epidemiological study of the association between anti-Lutzomyia longipalpis saliva antibodies and development of delayed-type hypersensitivity to Leishmania antigen.
description
2010 nî lūn-bûn
@nan
2010 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
name
Epidemiological study of the a ...... itivity to Leishmania antigen.
@ast
Epidemiological study of the a ...... itivity to Leishmania antigen.
@en
Epidemiological study of the a ...... itivity to Leishmania antigen.
@nl
type
label
Epidemiological study of the a ...... itivity to Leishmania antigen.
@ast
Epidemiological study of the a ...... itivity to Leishmania antigen.
@en
Epidemiological study of the a ...... itivity to Leishmania antigen.
@nl
prefLabel
Epidemiological study of the a ...... itivity to Leishmania antigen.
@ast
Epidemiological study of the a ...... itivity to Leishmania antigen.
@en
Epidemiological study of the a ...... itivity to Leishmania antigen.
@nl
P2093
P2860
P1476
Epidemiological study of the a ...... itivity to Leishmania antigen.
@en
P2093
Aldina Barral
Antonio A M Silva
Arlene J M Caldas
Dorlene M C Aquino
José Carlos Miranda
P2860
P304
P356
10.4269/AJTMH.2010.10-0182
P407
P577
2010-10-01T00:00:00Z